| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 05/12/2004 | EP1163208B1 Caspase inhibitors and uses thereof |
| 05/12/2004 | EP1161410B1 Retinoid antagonists and use thereof |
| 05/12/2004 | EP1151756A4 Application of polyacrylamide gel for forming a capsule in the tissue of a mammal organism, method for cultivating cells and method for therapy of oncological diseases and the diabetes mellitus |
| 05/12/2004 | EP1007556B1 Troponin subunits and fragments useful as angiogenesis inhibitors |
| 05/12/2004 | EP0971731B1 Suppression of malignancy utilizing ribonucleotide reductase r1 |
| 05/12/2004 | EP0969720A4 Combined tumor suppressor gene therapy and chemotherapy in the treatment of neoplasms |
| 05/12/2004 | EP0917464B1 Use of amines to produce drugs for preventing tumour cell proliferation |
| 05/12/2004 | EP0815240B1 Novel human cyclin-dependent kinase-like proteins and methods of using the same |
| 05/12/2004 | EP0781092B1 Nucleic acid encoding adenovirus e1a polypeptide for sensitizing tumor cells to chemotherapy or irradiation |
| 05/12/2004 | CN1496364A Substituted quinazoline derivatives and their use as inhibitors |
| 05/12/2004 | CN1496363A Process for preparation of imidazole compounds |
| 05/12/2004 | CN1496361A 苯基衍生物3 Phenyl derivative 3 |
| 05/12/2004 | CN1496360A Imidazolidine derivatives, their preparation, and their use as antinflamatory agent |
| 05/12/2004 | CN1496354A Quinoline, isoquinoline and phthalazine derivatives as antagonists of gonadotropin-releasing hormone |
| 05/12/2004 | CN1496351A 药用活性哌啶衍生物 Pharmaceutically active piperidine derivatives |
| 05/12/2004 | CN1496269A Medical composition containing P43 protein and taxol for curing cancer, curing method and use using the same thereof |
| 05/12/2004 | CN1496268A Vesicular stromatitis virus (VSV) |
| 05/12/2004 | CN1496260A Method for increasing leptin levels using nicotinic acid compounds |
| 05/12/2004 | CN1496258A Methods of administering epothilone analogs for treatment of cancer |
| 05/12/2004 | CN1496257A Benzimidazole compounds for modulating igE and inhibiting cellular proliferation |
| 05/12/2004 | CN1496256A Combination of EPOTHILONE analogs and chemotherapeutic agents for treatment of proliferative diseases |
| 05/12/2004 | CN1495262A Non-splicing variant of gp 350/220 |
| 05/12/2004 | CN1495253A Condition culture medium containing factor for inhibiting cancer cell multiplication and its preparation method |
| 05/12/2004 | CN1495184A Substituted purine derivative, its preparation method, application and composition containing it |
| 05/12/2004 | CN1495182A Substituted diindolyl maleimide for inhibiting cell proliferation |
| 05/12/2004 | CN1495177A C-10 position paclitaxane derivative and its medicine composition |
| 05/12/2004 | CN1495172A Irreversible inhibitor of tyrosine kinase |
| 05/12/2004 | CN1495171A Indazol compound for inhibiting protein kinase and medicine composition and their application |
| 05/12/2004 | CN1495169A Pyridine-3-carboxylic acid derivative |
| 05/12/2004 | CN1494919A Embonate medicine composition containing bombesin-like product |
| 05/12/2004 | CN1494918A Medicine composite for curing cancers and its preparation method |
| 05/12/2004 | CN1494910A Medicine containing pulsatilla root extuact as active component for curing solid tumor |
| 05/12/2004 | CN1494906A Application of compound in preparation of medicine for preventing and curing multiple drug resistance |
| 05/12/2004 | CN1494905A Medicine composition containing anti-tumor medicine and hydroximic acid derivative and having anti-tumor enhanced acitity and/or reducing side effect |
| 05/12/2004 | CN1494902A Application of high-solubility berberine in preparation of medicine. |
| 05/12/2004 | CN1149224C Monoclonal antibody which recognizes the oligosaccharide N-glycolylated-galactose-glucose sialic acid in malignant tumors, and composition containing it |
| 05/12/2004 | CN1149219C New compounds for treatment of cancer |
| 05/12/2004 | CN1149215C Phenyl Yanthine derivatives |
| 05/12/2004 | CN1149204C 1-heterocycle substd. diarylamines |
| 05/12/2004 | CN1149196C Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |
| 05/12/2004 | CN1149193C Substituted tricyclic compound |
| 05/12/2004 | CN1149191C Azetidine derivatives, Preparation and medicines containing them |
| 05/12/2004 | CN1149085C Inhibition of RAF kinase using substituted heterocyclic useas |
| 05/12/2004 | CN1149082C Di-and trivalent small molecule selecting protein inhibitors |
| 05/11/2004 | US6734308 Crystal forms of 6-[(4-chloro-phenyl)-hydroxy-(3-methyl-3H-imidazol-4-yl)-methyl]-4-(3-ethynyl-phenyl)-1-methyl-1H-quinolin-2-one, 2,3,- dihydroxybutanedioate salts and method of production |
| 05/11/2004 | US6734306 N-benzenesulfonyl L-proline compounds as bradykinin antagonists |
| 05/11/2004 | US6734302 Cis-imidazolines |
| 05/11/2004 | US6734295 Modified CRE recombinase gene for mammals |
| 05/11/2004 | US6734212 Methods and compositions for treating or preventing bacterial infection |
| 05/11/2004 | US6734203 Fused imidazolium derivatives |
| 05/11/2004 | US6734189 Hydroxamic and carboxylic acid derivatives |
| 05/11/2004 | US6734183 Useful as metalloproteinase inhibitor; piperazino-sulfonamide or piperidino-sulfonamide compound |
| 05/11/2004 | US6734178 Contacting host with a cephalotaxine and an antiproliferative agent such as an alkylating agent, an intercalating agent, a metal coordination complex, a nucleoside, a nucleic acid enyme or protein inhibitor to modulate cell proliferation |
| 05/11/2004 | US6734177 Certain salts of discodermolide acid, pharmaceutical compositions containing them and their use in treating tumors |
| 05/11/2004 | US6734174 Modulators of the function of receptors of the TNF/NGF receptor |
| 05/11/2004 | US6734168 Endothelial monocyte activating polypeptide II: a mediator which activates host response |
| 05/11/2004 | US6734167 Uses of transport proteins |
| 05/11/2004 | US6734163 Administering composition of tissure factor pathway inhibitor, homolog or active fragment with anti-proliferative activity; treating angiogenesis related diseases; cancer; arthritis; macular degeneration; diabetic retinopathy |
| 05/11/2004 | US6734013 Genetic engineering |
| 05/11/2004 | US6733994 Highly expressible genes |
| 05/11/2004 | US6733978 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 05/11/2004 | US6733801 Method of using fermented glycine max (L) extract for enhancing natural killer cell activity |
| 05/11/2004 | US6733792 Arsenic sulfide compounds and derivatives thereof for the treatment of malignancies |
| 05/11/2004 | US6733763 Using antigen; oil in water emulsion |
| 05/11/2004 | US6733755 Ligand for vascular endothelial growth factor receptor |
| 05/11/2004 | US6733748 Chronic lymphocytic leukemia treatment |
| 05/11/2004 | US6733743 Methods to impair hematologic cancer progenitor cells and compounds related thereto |
| 05/07/2004 | CA2448481A1 A cell therapy method for the treatment of tumors |
| 05/06/2004 | WO2004038408A2 Diagnostics and therapeutics for diseases associated with human g-protein coupled receptor 14 (gpr14) |
| 05/06/2004 | WO2004038407A2 Diagnostics and therapeutics for diseases associated with human g-protein coupled receptor 12 (gpr12) |
| 05/06/2004 | WO2004038406A2 Diagnostics and therapeutics for diseases associated with human g protein-coupled receptor 42 (gpr42) |
| 05/06/2004 | WO2004038405A2 Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 43 (gpr43) |
| 05/06/2004 | WO2004038374A2 Alkyne derivatives as tracers for metabotropic glutamate receptor binding |
| 05/06/2004 | WO2004038020A1 Target genes for the diagnosis and treatment of cancer |
| 05/06/2004 | WO2004038006A2 Purine nucleosides |
| 05/06/2004 | WO2004037831A1 Novel substituted[1,4]benzodioxino[2,3-e]isoindole derivatives, method for preparing same and pharmaceutical compositions containing same |
| 05/06/2004 | WO2004037830A1 Substituted benzol[e] [1,4] oxazino[3,2-g] isoindole derivatives, method for preparing same and pharmaceutical compositions containing same |
| 05/06/2004 | WO2004037829A1 Novel benzoxazole or oxazolopyridine compounds, method for preparing same and pharmaceutical compositions containing same |
| 05/06/2004 | WO2004037821A1 Pyridoindolone derivatives substituted in the 3-position by a heterocyclic group, preparation thereof and application of same in therapeutics |
| 05/06/2004 | WO2004037812A1 Heterocyclic compounds and antitumor drugs containing the same as the active ingredient |
| 05/06/2004 | WO2004037321A2 Immunotherapy of cancer through controlled cell lysis |
| 05/06/2004 | WO2004037288A1 Agent eleveting dendritic cell precursor level in blood |
| 05/06/2004 | WO2004037286A2 Combination of a trioxopyrimidine compound inhibitor and an anti-tumor agent, and uses thereof |
| 05/06/2004 | WO2004037284A1 Anti-cancer vaccines and high-dose cytokines as adjuvants |
| 05/06/2004 | WO2004037269A1 Pharmaceutical compositions comprising estetrol derivatives for use in cancer therapy |
| 05/06/2004 | WO2004037258A1 A combination comprising combretastatin and anticancer agents |
| 05/06/2004 | WO2004037235A2 Method and composition for preventing and treating solid tumors |
| 05/06/2004 | WO2004037187A2 Metal-containing materials, compositions and methods |
| 05/06/2004 | WO2004037182A2 Active specific immunotherapy of cancer metastasis |
| 05/06/2004 | WO2004037173A2 Method for treating erectile dysfunction and increasing libido in men |
| 05/06/2004 | WO2004037161A2 Cyclic prodrugs of pmea one of its analogues |
| 05/06/2004 | WO2004018044A3 N-(3-methoxy-5-methylpyrazin-2-yl)-2-(4-'1,3,4-oxadiazol-2-yl!phenyl)pyridine-3 sulphonamide as an anticancer agent |
| 05/06/2004 | WO2004016614A3 Pyrrolopyrazines as kinase inhibitors |
| 05/06/2004 | WO2004011460A3 Pyrazolylbenzothiazole derivatives and their use as therapeutic agents |
| 05/06/2004 | WO2004011423A3 Structural carotenoid analogs for the inhibition and amelioration of disease |
| 05/06/2004 | WO2004009585A3 Acyloxypyrrolidine derivatives and use thereof as ligands of v1b or both v1b and v1a receptors |
| 05/06/2004 | WO2004005281A8 Inhibitors of tyrosine kinases |
| 05/06/2004 | WO2004003562A3 Oncolytic viruses as phenotyping agents for neoplasms |
| 05/06/2004 | WO2004003174A3 Method of up-regulating tumor antigen expression using thymalfasin |
| 05/06/2004 | WO2004000042A3 Method and composition for treating or preventing catabolism or stimulating anabolism in a mammal undergoing metabolic stress |